These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

256 related articles for article (PubMed ID: 14689101)

  • 21. The metabolic syndrome and its cardiovascular manifestations.
    Sánchez-Torres RJ; Delgado-Osorio H
    Bol Asoc Med P R; 2005; 97(4):271-80. PubMed ID: 16599068
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Management issues in the metabolic syndrome.
    Deedwania PC; Gupta R
    J Assoc Physicians India; 2006 Oct; 54():797-810. PubMed ID: 17214277
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Diagnosis, prevention, and intervention for the metabolic syndrome.
    Scott CL
    Am J Cardiol; 2003 Jul; 92(1A):35i-42i. PubMed ID: 12867253
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Telmisartan is a promising cardiometabolic sartan due to its unique PPAR-gamma-inducing property.
    Yamagishi S; Takeuchi M
    Med Hypotheses; 2005; 64(3):476-8. PubMed ID: 15617852
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Management of the metabolic syndrome.
    Scheen AJ
    Minerva Endocrinol; 2004 Jun; 29(2):31-45. PubMed ID: 15257254
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Recent intervention studies with antihypertensive drugs and their influence on guidelines].
    Rahn KH
    Med Klin (Munich); 2003 Dec; 98(12):771-5. PubMed ID: 14685679
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Atherosclerosis in type 2 diabetes mellitus: the role of insulin resistance.
    Watson KE; Peters Harmel AL; Matson G
    J Cardiovasc Pharmacol Ther; 2003 Dec; 8(4):253-60. PubMed ID: 14740074
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Long-standing therapy of the metabolic syndrome in diabetics after coronary artery bypass surgery].
    Steinmetz A
    Clin Res Cardiol; 2006 Jan; 95 Suppl 1():i110-6. PubMed ID: 16598537
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Exercise in arterial hypertension].
    Predel HG; Schramm T
    Herz; 2006 Sep; 31(6):525-30. PubMed ID: 17036183
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Pharmacological basis of antihypertensive drug therapy].
    Kolck UW; Zaugg CE; Erne P
    Praxis (Bern 1994); 2004 May; 93(20):847-56. PubMed ID: 15195836
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Hypertension and diabetes].
    Bouhanick B; Laboureau-Soares Barbosa S; Marre M
    Arch Mal Coeur Vaiss; 2000 Nov; 93(11 Suppl):1429-34. PubMed ID: 11190292
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pharmacological treatment and therapeutic perspectives of metabolic syndrome.
    Lim S; Eckel RH
    Rev Endocr Metab Disord; 2014 Dec; 15(4):329-41. PubMed ID: 25342235
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Strategies in ongoing clinical trials to reduce cardiovascular disease in patients with diabetes mellitus and insulin resistance.
    Mazzone T
    Am J Cardiol; 2004 Jun; 93(11A):27C-31C. PubMed ID: 15178514
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Retrospective studies and prospects of therapy for hypertension].
    Maisch B; Brilla C; Kruse T; Noll B; Bethge C
    Herz; 1995 Dec; 20(6):370-89. PubMed ID: 8582697
    [TBL] [Abstract][Full Text] [Related]  

  • 35. New treatment guidelines for a patient with diabetes and hypertension.
    Mogensen CE
    J Hypertens Suppl; 2003 Mar; 21(1):S25-30. PubMed ID: 12769164
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Irbesartan for the treatment of hypertension in patients with the metabolic syndrome: a sub analysis of the Treat to Target post authorization survey. Prospective observational, two armed study in 14,200 patients.
    Kintscher U; Bramlage P; Paar WD; Thoenes M; Unger T
    Cardiovasc Diabetol; 2007 Apr; 6():12. PubMed ID: 17407587
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The 2005 Canadian Hypertension Education Program recommendations for the management of hypertension: part II - therapy.
    Khan NA; McAlister FA; Lewanczuk RZ; Touyz RM; Padwal R; Rabkin SW; Leiter LA; Lebel M; Herbert C; Schiffrin EL; Herman RJ; Hamet P; Fodor G; Carruthers G; Culleton B; DeChamplain J; Pylypchuk G; Logan AG; Gledhill N; Petrella R; Campbell NR; Arnold M; Moe G; Hill MD; Jones C; Larochelle P; Ogilvie RI; Tobe S; Houlden R; Burgess E; Feldman RD;
    Can J Cardiol; 2005 Jun; 21(8):657-72. PubMed ID: 16003449
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Metabolic syndrome].
    Wirth A; Rothenfelde B
    Versicherungsmedizin; 1996 Dec; 48(6):193-9. PubMed ID: 9082643
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Insulin resistance: an etiological factor in essential arterial hypertension and coronary cardiopathy].
    Vázquez Chávez C; Brito Zurita OR; Argüero Sánchez R; Lozano de los Santos H
    Gac Med Mex; 1993; 129(5):339-45. PubMed ID: 7926420
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Metabolic syndrome: a work in progress, but a useful construct.
    Beaser RS; Levy P
    Circulation; 2007 Apr; 115(13):1812-8; discussion 1818. PubMed ID: 17404172
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.